Consultation News and Research

RSS

Ampio completes partial planned interim review in Optina trial for diabetic macular edema

Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.

19 Mar 2012

States considering wide-ranging abortion, contraception legislation give lingering voice to issue

A host of abortion legislation is winding its way through state legislatures: Democrats are focusing on regulating male reproductive health in at least six states; Michigan abortion providers face greater scrutiny; Arizona could require those seeking birth control give a medical reason they need it; and Wisconsin lawmakers decide if a doctor must be present to give abortion pills.

17 Mar 2012

New Aspen Dental office to open on March 29 in Walpole, MA

Patients looking for a dentist in Walpole, MA now have a new dental care provider option with the opening of a new Aspen Dental office this month. The new practice, which opens on Thursday, March 29 in the Walpole Mall at 116 Providence Hwy., will provide dental services that range from dentures and preventive care to general dentistry and restoration.

17 Mar 2012

New Aspen Dental office to open on March 29 in Spring Hill, FL

Patients looking for a dentist in Spring Hill, FL now have a new dental care provider option with the opening of a new Aspen Dental office this month. The new practice, which opens on Thursday, March 29 in the Spring Hill at 1525 Commercial Way, will provide dental services that range from dentures and preventive care to general dentistry and restoration.

17 Mar 2012

Thermo Fisher launches HyCell CHO medium

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyCell CHO cell-culture medium, a versatile animal-derived- component-free (ADCF) and chemically defined (CD) medium for culturing a broad variety of CHO cells.

From Thermo Fisher Scientific Inc. 17 Mar 2012

New UCLA Alzheimer's and Dementia Care program for patients, caregivers

Alzheimer's disease affects an estimated 5.4 million people in the U.S., some 480,000 of them in California. Nearly half of all people 85 and older will be stricken with the disease. The overall burden of dementia is still higher, with Alzheimer's accounting for only 60 to 80 percent of dementia cases.

15 Mar 2012

Homeopathy could soon be declared “baseless and unethical” in Australia

Homeopathy is a branch of alternative medicine based on the principles of “like-cures-like” and “ultra-dilutions”. The first principle says substances that can cause symptoms can be used in diluted form to treat the same symptom in an illness, and the second says the more dilute a substance is, the more potent it is.

14 Mar 2012

New insight into causes of childhood pneumonia

The scientific journal Clinical Infectious Diseases has released its March Special Supplement focusing entirely on the research design of and pilot data from the Pneumonia Etiology Research for Child Health (PERCH) Project, which seeks to identify the causes of pneumonia among the world's most vulnerable populations.

12 Mar 2012

Researchers to create and test novel interventions for older adult care

One in every eight Americans is aged 65 years or older and, by 2030, it is expected to be one in five. As the number of older Americans increases, healthcare providers and researchers must understand and address the needs of this growing population.

12 Mar 2012

Root cause of dental phobia

Women in their forties are more likely to have dental anxiety than any other age group according to a University of Sydney study into dental anxiety and phobia.

11 Mar 2012

March issue of NeuroPerspective reviews therapeutics for ADHD

NeuroPerspective, the independent, monthly review of the neurotherapeutics area, has released its March issue, which reviews the field of therapeutics for Attention Deficit Disorder.

8 Mar 2012

USA Wrestling to gain access to NYU Langone's orthopaedic experts

USA Wrestling, the national governing body for amateur wrestling in the United States, announced today that the Department of Orthopaedic Surgery at NYU Langone Medical Center is an official sponsor and medical consultant, through September 2014.

6 Mar 2012

Butler Hospital expands Outpatient Psychiatric Consultation Program

In a move that highlights collaboration across a health care system, three Care New England hospitals recently came together to pilot a service that is now being expanded to fill a need for mental health services in the entire region. After successfully piloting the concept at Women & Infants and Kent hospitals, Butler Hospital is expanding its Outpatient Psychiatric Consultation Program to all referring physicians in the area who may have a patient needing a consult.

6 Mar 2012

HIV among injection drug users declines

U.S. health officials say the rate has dropped by half since the 1990s. The decline may be related to a growth in needle exchange programs. For the report more than 10,000 drug users in 20 metropolitan areas were surveyed and tested for HIV in 2009. About 1 in 10 tested positive for the virus. In the '90s, roughly 1 in 5 did. Addicts who inject heroin, cocaine or other drugs have been one of the groups hit hardest by AIDS.

2 Mar 2012

Scientists identify genetic defect responsible for TAR Syndrome

Universitätsmedizin Berlin in collaboration with the Sanger Institute in Cambridge and other cooperation partners in Belgium, the Netherlands and France, were able to identify a genetic defect that is responsible for the development of TAR Syndrome, a congenital malformation of the skeleton and blood.

1 Mar 2012

Expertise guide to facilitate use of QSARs under EU REACH Program

Seeking to maximise the value of computational modelling in avoiding animal testing for the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the People for the Ethical Treatment of Animals (PETA) Foundation has produced a free resource for chemical companies, identifying sources of information and expertise on the use of Quantitative Structure Activity Relationships (QSARs).

1 Mar 2012